Two Sigma Advisers’s Tabula Rasa HealthCare TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-241,600
Closed -$2.49M – 2700
2023
Q3
$2.49M Buy
241,600
+21,700
+10% +$206K 0.01% 1078
2023
Q2
$1.81M Buy
219,900
+103,400
+89% +$619K ﹤0.01% 1255
2023
Q1
$651K Sell
116,500
-61,000
-34% -$349K ﹤0.01% 1829
2022
Q4
$879K Sell
177,500
-152,514
-46% -$628K ﹤0.01% 1631
2022
Q3
$1.58M Buy
330,014
+77,814
+31% +$334K ﹤0.01% 1289
2022
Q2
$648K Sell
252,200
-186,000
-42% -$698K ﹤0.01% 1805
2022
Q1
$2.52M Buy
+438,200
New +$3.93M 0.01% 1119
2018
Q4
– Sell
-5,300
Closed -$430K – 2498
2018
Q3
$430K Buy
+5,300
New +$388K ﹤0.01% 1853

Other funds holding TRHC

Two Sigma Advisers's TRHC Position: Q4 2023 in Review

Two Sigma Advisers sold out of Tabula Rasa HealthCare (TRHC) in Q4 2023, closing a stake of 241,600 shares — an estimated $2.49M sold.

Two Sigma Advisers first reported a position in TRHC in Q3 2018 and held it in 8 quarters. The position peaked at $2.52M in Q1 2022. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

  • Two Sigma Advisers reported no remaining Tabula Rasa HealthCare position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 241,600 Tabula Rasa HealthCare shares in Q4 2023, an estimated $2.49M.
  • Two Sigma Advisers first reported a position in Tabula Rasa HealthCare in Q3 2018 and held it in 8 quarters.
  • Two Sigma Advisers's Tabula Rasa HealthCare position peaked at $2.52M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare as of Q4 2023.

Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.